Barron’s likes BMY on valuation: https://www.barrons.com/articles/buy-bristol-myers-stock-pick-51653520520 …simply getting back to its five-year average [P/E] multiple of 11.7 times would put Bristol stock at $91.38…while getting to Merck’s 13 times would put the shares at $101.53… BMY's performance in 2022 YTD has been pretty good, but the stock is still cheap.